• Japanese
  • Korean
  • Chinese
Cover Image

Global Pharmaceuticals Market 2011-2015

Abstract

TechNavio's analysts forecast the Global Pharmaceuticals market to grow at a CAGR of 7 percent over the period 2011-2015. One of the key factors contributing to this market growth is the rising demand of drugs in the emerging markets. The Global Pharmaceuticals market has also been witnessing a paradigm shift towards biologic drugs. However, the patent expiration of top-selling drugs could pose a challenge to the growth of this market.

TechNavio's report, the Global Pharmaceuticals Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Pharmaceuticals market landscape by Chemical Properties, by Commercialization, by Legal Consideration, and by Therapeutic Area, and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., and Roche Holding Ltd.

Other vendors mentioned in the report: Abbott Laboratories Inc., Amgen Inc., Astellas Pharma Inc., AstraZeneca plc., Baxter International Inc., Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Co., Celgene Corp., Cephalon Inc., Eisai Co. Ltd., Eli Lilly and Co., Forest Laboratories Inc., GlaxoSmithKline plc., Hospira Inc., Johnson & Johnson Ltd., Mylan Inc., Novo Nordisk A/S, Otsuka Holdings Co. Ltd., Schering-Plough Corp., Shire plc., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical, and UCB S.A.

Key questions answered in this report:

  • What will the market size be in 2015 and at what rate will it grow?
  • What key trends is this market subject to?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the opportunities and threats faced by each of these key vendors?
  • What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of analyst time when you purchase this report. Details provided within the report.

Table of Contents

01. Executive Summary

02. Introduction

03. Market Coverage

  • Market Overview
  • Product Offerings

04. Market Landscape

  • Market Size
  • 04.1. Global Pharmaceuticals Market Segmentation
  • 04.2. Market Segmentation by Chemical Property
    • Global Biopharmaceuticals Market
    • Global Chemically Synthesized Drugs Market
  • 04.3. Market Segmentation by Commercialization
    • Global Generic Drugs Market
    • Global Branded Drugs Market
  • 04.4. Market Segmentation by Legal Consideration
    • Global Prescription Drugs Market
    • Global Over-the-counter Drugs Market
  • 04.5. Market Segmentation by Therapeutic Area
    • Global Cancer Drugs Market
    • Global Musculoskeletal Drugs Market
    • Global Gastrointestinal Drugs Market
    • Global Ophthalmology Drugs Market
    • Five Forces Analysis

05. Geographical Segmentation

06. Key Leading Countries

  • USA
  • Japan
  • Germany
  • Economic Indicators of Key Leading Countries

07. Rate of Incidence and Prevalence

  • Cardiovascular Diseases
  • Neurological Disorders
  • Cancer
  • Diabetes
  • Musculoskeletal Diseases

08. Vendor Landscape

  • 08.1. Global Pharmaceuticals Market
  • 08.2. Global Biopharmaceuticals Market
  • 08.3. Global Generic Drugs Market
  • 08.4. Global Branded Drugs Market
    • Product Portfolio Matrix

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Key Vendor Analysis

  • 15.1. Pfizer Inc.
    • Business Overview
    • SWOT Analysis
  • 15.2. Novartis AG
    • Business Overview
    • SWOT Analysis
  • 15.3. Merck and Co. Inc.
    • Business Overview
    • SWOT Analysis
  • 15.4. Sanofi S.A.
    • Business Overview
    • SWOT Analysis
  • 15.5. Roche Holding Ltd.
    • Business Overview
    • SWOT Analysis

16. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Global Pharmaceuticals Market 2011-2015 (US$ billion)
  • Exhibit 2: Global Pharmaceuticals Market Segmentation
  • Exhibit 3: Market Segmentation by Chemical Property
  • Exhibit 4: Global Pharmaceuticals Market Segmentation by Chemical Property 2011
  • Exhibit 5: Global Biopharmaceuticals Market 2011-2015 (US$ billion)
  • Exhibit 6: Global Chemically Synthesized Drugs Market 2011-2015 (US$ billion)
  • Exhibit 7: Market Segmentation by Commercialization
  • Exhibit 8: Global Pharmaceuticals Market Segmentation by Commercialization 2011
  • Exhibit 9: Global Generic Drugs Market 2011-2015 (US$ billion)
  • Exhibit 10: Global Branded Drugs Market 2011-2015 (US$ billion)
  • Exhibit 11: Market Segmentation by Legal Consideration
  • Exhibit 12: Global Pharmaceuticals Market Segmentation by Legal Consideration 2011
  • Exhibit 13: Global Prescription Drugs Market 2011-2015 (US$ billion)
  • Exhibit 14: Global Over-the-counter Drugs Market 2011-2015 (US$ billion)
  • Exhibit 15: Market Segmentation by Therapeutic Area 2011
  • Exhibit 16: Global Pharmaceuticals Market Segmentation by Therapeutic Area 2011
  • Exhibit 17: Global Pharmaceuticals Market Segmentation by Therapeutic Area 2011-2015 (percentage)
  • Exhibit 18: Global Pharmaceuticals Market Segmentation by Therapeutic Area 2011-2015 (US$ billion)
  • Exhibit 19: Global Cancer Drugs Market 2011-2015 (US$ billion)
  • Exhibit 20: Global Musculoskeletal Drugs Market 2011-2015 (US$ billion)
  • Exhibit 21: Global Gastrointestinal Drugs Market 2011-2015 (US$ billion)
  • Exhibit 22: Global Ophthalmology Drugs Market 2011-2015 (US$ billion)
  • Exhibit 23: Global Pharmaceuticals Market by Geographical Segmentation 2011
  • Exhibit 24: Global Pharmaceuticals Market by Vendor Segmentation 2011
  • Exhibit 25: Global Biopharmaceuticals Market by Vendor Segmentation 2011
  • Exhibit 26: Global Generic Drugs Market by Vendor Segmentation 2011
  • Exhibit 27: Global Branded Drugs Market by Vendor Segmentation 2011
Show More
Pricing
Get Notified
Email me when related reports are published